This Week in Biotech

Published February 16, 2013

This Week in Biotech

Filed under: free drug treatment programs

Leading with the positive, ZIOPHARM Oncology (NASDAQ: ZIOP ) reported that its metastatic soft tissue sarcoma drug, palifosfamide, had reached the required number of progression-free survival events as outlined in its stage 3 trial to begin analyzing …
Read more on Motley Fool

What's the Buzz with Phil Rothfield

Filed under: free drug treatment programs

The Australian Crime Commission would be better off investigating the crooks in this sport rather than making unsubstantiated claims of drug use, organised crime and match fixing in the footy codes. SHOOSH A disgusting photo is doing the rounds, …
Read more on The Daily Telegraph

2013, A Year Of Turmoil For Eli Lilly

Filed under: free drug treatment programs

Five out of the last six drugs that have come through Lilly's pipeline have either been rejected by the FDA or failed their Phase III trial outright. 2012 was a horrendous year in the clinic, with 2 of the biggest failures (Pomaglumetad methionil mGlu2 …
Read more on Seeking Alpha